Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 194

1.

A non-cell-autonomous role for Pml in the maintenance of leukemia from the niche.

Guarnerio J, Mendez LM, Asada N, Menon AV, Fung J, Berry K, Frenette PS, Ito K, Pandolfi PP.

Nat Commun. 2018 Jan 4;9(1):66. doi: 10.1038/s41467-017-02427-x.

2.

Latency Entry of Herpes Simplex Virus 1 Is Determined by the Interaction of Its Genome with the Nuclear Environment.

Maroui MA, Callé A, Cohen C, Streichenberger N, Texier P, Takissian J, Rousseau A, Poccardi N, Welsch J, Corpet A, Schaeffer L, Labetoulle M, Lomonte P.

PLoS Pathog. 2016 Sep 12;12(9):e1005834. doi: 10.1371/journal.ppat.1005834. eCollection 2016 Sep.

3.

PML regulates neuroprotective innate immunity and neuroblast commitment in a hypoxic-ischemic encephalopathy model.

Palibrk V, Suganthan R, Scheffler K, Wang W, Bjørås M, Bøe SO.

Cell Death Dis. 2016 Jul 28;7(7):e2320. doi: 10.1038/cddis.2016.223.

4.

Localization and regulation of PML bodies in the adult mouse brain.

Hall MH, Magalska A, Malinowska M, Ruszczycki B, Czaban I, Patel S, Ambrożek-Latecka M, Zołocińska E, Broszkiewicz H, Parobczak K, Nair RR, Rylski M, Pawlak R, Bramham CR, Wilczyński GM.

Brain Struct Funct. 2016 Jun;221(5):2511-25. doi: 10.1007/s00429-015-1053-4. Epub 2015 May 9.

PMID:
25956166
5.

Promyelocytic leukemia protein is a cell-intrinsic factor inhibiting parvovirus DNA replication.

Mitchell AM, Hirsch ML, Li C, Samulski RJ.

J Virol. 2014 Jan;88(2):925-36. doi: 10.1128/JVI.02922-13. Epub 2013 Nov 6.

6.

Promyelocytic leukemia protein modulates establishment and maintenance of latent gammaherpesvirus infection in peritoneal cells.

Sewatanon J, Liu H, Ling PD.

J Virol. 2013 Nov;87(22):12151-7. doi: 10.1128/JVI.01696-13. Epub 2013 Aug 28.

7.

Ablation of promyelocytic leukemia protein (PML) re-patterns energy balance and protects mice from obesity induced by a Western diet.

Cheng X, Guo S, Liu Y, Chu H, Hakimi P, Berger NA, Hanson RW, Kao HY.

J Biol Chem. 2013 Oct 11;288(41):29746-59. doi: 10.1074/jbc.M113.487595. Epub 2013 Aug 28.

8.

Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner.

Haupt S, Mitchell C, Corneille V, Shortt J, Fox S, Pandolfi PP, Castillo-Martin M, Bonal DM, Cordon-Cardo C, Lozano G, Haupt Y.

Cell Cycle. 2013 Jun 1;12(11):1722-31. doi: 10.4161/cc.24805. Epub 2013 May 8.

9.

Impaired cognitive function and reduced anxiety-related behavior in a promyelocytic leukemia (PML) tumor suppressor protein-deficient mouse.

Butler K, Martinez LA, Tejada-Simon MV.

Genes Brain Behav. 2013 Mar;12(2):189-202. doi: 10.1111/gbb.12014. Epub 2013 Jan 18.

10.

Deficiency of the promyelocytic leukemia protein fosters hepatitis C-associated hepatocarcinogenesis in mice.

Herzer K, Carbow A, Sydor S, Sowa JP, Biesterfeld S, Hofmann TG, Galle PR, Gerken G, Canbay A.

PLoS One. 2012;7(9):e44474. doi: 10.1371/journal.pone.0044474. Epub 2012 Sep 11.

11.

Promyelocytic leukemia inhibits adipogenesis, and loss of promyelocytic leukemia results in fat accumulation in mice.

Kim MK, Yang S, Lee KH, Um JH, Liu M, Kang H, Park SJ, Chung JH.

Am J Physiol Endocrinol Metab. 2011 Dec;301(6):E1130-42. doi: 10.1152/ajpendo.00092.2011. Epub 2011 Aug 16.

12.

A Role for PML in Innate Immunity.

Lunardi A, Gaboli M, Giorgio M, Rivi R, Bygrave A, Antoniou M, Drabek D, Dzierzak E, Fagioli M, Salmena L, Botto M, Cordon-Cardo C, Luzzatto L, Pelicci PG, Grosveld F, Pandolfi PP.

Genes Cancer. 2011 Jan;2(1):10-9. doi: 10.1177/1947601911402682.

13.

PML-RAR{alpha} and Dnmt3a1 cooperate in vivo to promote acute promyelocytic leukemia.

Subramanyam D, Belair CD, Barry-Holson KQ, Lin H, Kogan SC, Passegué E, Blelloch R.

Cancer Res. 2010 Nov 1;70(21):8792-801. doi: 10.1158/0008-5472.CAN-08-4481. Epub 2010 Sep 21. Erratum in: Cancer Res. 2011 Apr 1;71(7):2805.

14.

Resistance to rabies virus infection conferred by the PMLIV isoform.

Blondel D, Kheddache S, Lahaye X, Dianoux L, Chelbi-Alix MK.

J Virol. 2010 Oct;84(20):10719-26. doi: 10.1128/JVI.01286-10. Epub 2010 Aug 11.

15.

PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3.

Jeanne M, Lallemand-Breitenbach V, Ferhi O, Koken M, Le Bras M, Duffort S, Peres L, Berthier C, Soilihi H, Raught B, de Thé H.

Cancer Cell. 2010 Jul 13;18(1):88-98. doi: 10.1016/j.ccr.2010.06.003.

16.

Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy.

Laane E, Tamm KP, Buentke E, Ito K, Kharaziha P, Oscarsson J, Corcoran M, Björklund AC, Hultenby K, Lundin J, Heyman M, Söderhäll S, Mazur J, Porwit A, Pandolfi PP, Zhivotovsky B, Panaretakis T, Grandér D.

Cell Death Differ. 2009 Jul;16(7):1018-29. doi: 10.1038/cdd.2009.46. Epub 2009 Apr 24. Erratum in: Cell Death Differ. 2009 Jul;16(7):1071. Khahariza, P [corrected to Kharaziha, P].

17.

PML targeting eradicates quiescent leukaemia-initiating cells.

Ito K, Bernardi R, Morotti A, Matsuoka S, Saglio G, Ikeda Y, Rosenblatt J, Avigan DE, Teruya-Feldstein J, Pandolfi PP.

Nature. 2008 Jun 19;453(7198):1072-8. doi: 10.1038/nature07016. Epub 2008 May 11.

18.

Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects.

Chee AV, Lopez P, Pandolfi PP, Roizman B.

J Virol. 2003 Jun;77(12):7101-5.

19.

Role of promyelocytic leukemia (PML) protein in tumor suppression.

Rego EM, Wang ZG, Peruzzi D, He LZ, Cordon-Cardo C, Pandolfi PP.

J Exp Med. 2001 Feb 19;193(4):521-29.

20.

An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer.

Chen M, Zhang J, Sampieri K, Clohessy JG, Mendez L, Gonzalez-Billalabeitia E, Liu XS, Lee YR, Fung J, Katon JM, Menon AV, Webster KA, Ng C, Palumbieri MD, Diolombi MS, Breitkopf SB, Teruya-Feldstein J, Signoretti S, Bronson RT, Asara JM, Castillo-Martin M, Cordon-Cardo C, Pandolfi PP.

Nat Genet. 2018 Feb;50(2):206-218. doi: 10.1038/s41588-017-0027-2. Epub 2018 Jan 15.

PMID:
29335545

Supplemental Content

Support Center